<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-11-01" modified="2018-01-31" version="208">
<accession>P08686</accession>
<accession>A2BHY6</accession>
<accession>P04033</accession>
<accession>Q01204</accession>
<accession>Q08AG8</accession>
<accession>Q16749</accession>
<accession>Q16806</accession>
<accession>Q5ST44</accession>
<accession>Q96NU8</accession>
<name>CP21A_HUMAN</name>
<protein>
<recommendedName>
<fullName>Steroid 21-hydroxylase</fullName>
<ecNumber evidence="33 42 44 45">1.14.14.16</ecNumber>
</recommendedName>
<alternativeName>
<fullName>21-OHase</fullName>
</alternativeName>
<alternativeName>
<fullName>Cytochrome P-450c21</fullName>
</alternativeName>
<alternativeName>
<fullName>Cytochrome P450 21</fullName>
</alternativeName>
<alternativeName>
<fullName>Cytochrome P450 XXI</fullName>
</alternativeName>
<alternativeName>
<fullName>Cytochrome P450-C21</fullName>
</alternativeName>
<alternativeName>
<fullName>Cytochrome P450-C21B</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">CYP21A2</name>
<name type="synonym">CYP21</name>
<name type="synonym">CYP21B</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1986" name="Proc. Natl. Acad. Sci. U.S.A." volume="83" first="2841" last="2845">
<title>Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene.</title>
<authorList>
<person name="Higashi Y."/>
<person name="Yoshioka H."/>
<person name="Yamane M."/>
<person name="Gotoh O."/>
<person name="Fujii-Kuriyama Y."/>
</authorList>
<dbReference type="PubMed" id="3486422"/>
<dbReference type="DOI" id="10.1073/pnas.83.9.2841"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE CYP21A2*1A)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1986" name="Proc. Natl. Acad. Sci. U.S.A." volume="83" first="5111" last="5115">
<title>Structure of human steroid 21-hydroxylase genes.</title>
<authorList>
<person name="White P.C."/>
<person name="New M.I."/>
<person name="Dupont B."/>
</authorList>
<dbReference type="PubMed" id="3487786"/>
<dbReference type="DOI" id="10.1073/pnas.83.14.5111"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ALLELE CYP21A2*1B) (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1987" name="EMBO J." volume="6" first="1653" last="1661">
<title>Molecular characterization of the HLA-linked steroid 21-hydroxylase B gene from an individual with congenital adrenal hyperplasia.</title>
<authorList>
<person name="Rodrigues N.R."/>
<person name="Dunham I."/>
<person name="Yu C.Y."/>
<person name="Carroll M.C."/>
<person name="Porter R.R."/>
<person name="Campbell R.D."/>
</authorList>
<dbReference type="PubMed" id="3038528"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT AH3 THR-268</scope>
<scope>VARIANTS LEU-9 INS; ARG-102 AND SER-493</scope>
<scope>INVOLVEMENT IN AH3</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1988" name="J. Clin. Invest." volume="82" first="139" last="144">
<title>Nonsense mutation causing steroid 21-hydroxylase deficiency.</title>
<authorList>
<person name="Globerman H."/>
<person name="Amor M."/>
<person name="Parker K.L."/>
<person name="New M.I."/>
<person name="White P.C."/>
</authorList>
<dbReference type="PubMed" id="3267225"/>
<dbReference type="DOI" id="10.1172/JCI113562"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT AH3 LEU-281</scope>
<scope>VARIANT LEU-9 INS</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1992" name="Mol. Endocrinol." volume="6" first="1318" last="1322">
<title>R339H and P453S: CYP21 mutations associated with nonclassic steroid 21-hydroxylase deficiency that are not apparent gene conversions.</title>
<authorList>
<person name="Helmberg A."/>
<person name="Tusie-Luna M.-T."/>
<person name="Tabarelli M."/>
<person name="Kofler R."/>
<person name="White P.C."/>
</authorList>
<dbReference type="PubMed" id="1406709"/>
<dbReference type="DOI" id="10.1210/mend.6.8.1406709"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS LEU-9 INS; ARG-102 AND SER-493</scope>
<scope>VARIANTS AH3 HIS-339 AND SER-453</scope>
<source>
<tissue>Peripheral blood</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2009" name="Mol. Immunol." volume="46" first="2623" last="2629">
<title>Linkage analysis of the C4A/C4B copy number variation and polymorphisms of the adjacent steroid 21-hydroxylase gene in a healthy population.</title>
<authorList>
<person name="Blasko B."/>
<person name="Banlaki Z."/>
<person name="Gyapay G."/>
<person name="Pozsonyi E."/>
<person name="Sasvari-Szekely M."/>
<person name="Rajczy K."/>
<person name="Fust G."/>
<person name="Szilagyi A."/>
</authorList>
<dbReference type="PubMed" id="19505723"/>
<dbReference type="DOI" id="10.1016/j.molimm.2009.04.033"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE CYP21A2*6) (ISOFORM 2)</scope>
<source>
<tissue>Adrenal gland</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="Nature" volume="425" first="805" last="811">
<title>The DNA sequence and analysis of human chromosome 6.</title>
<authorList>
<person name="Mungall A.J."/>
<person name="Palmer S.A."/>
<person name="Sims S.K."/>
<person name="Edwards C.A."/>
<person name="Ashurst J.L."/>
<person name="Wilming L."/>
<person name="Jones M.C."/>
<person name="Horton R."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Gilbert J.G.R."/>
<person name="Clamp M.E."/>
<person name="Bethel G."/>
<person name="Milne S."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Andrews T.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bray-Allen S."/>
<person name="Brook J."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clark G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Collins J.E."/>
<person name="Colman L.K."/>
<person name="Corby N.R."/>
<person name="Coville G.J."/>
<person name="Culley K.M."/>
<person name="Dhami P."/>
<person name="Davies J."/>
<person name="Dunn M."/>
<person name="Earthrowl M.E."/>
<person name="Ellington A.E."/>
<person name="Evans K.A."/>
<person name="Faulkner L."/>
<person name="Francis M.D."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori M.J."/>
<person name="Gilby L.M."/>
<person name="Gillson C.J."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Grant M."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Hall R."/>
<person name="Halls K.S."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Heathcott R."/>
<person name="Holmes S.J."/>
<person name="Howden P.J."/>
<person name="Howe K.L."/>
<person name="Howell G.R."/>
<person name="Huckle E."/>
<person name="Humphray S.J."/>
<person name="Humphries M.D."/>
<person name="Hunt A.R."/>
<person name="Johnson C.M."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S.J."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C.R."/>
<person name="Lloyd D.M."/>
<person name="Loveland J.E."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Maslen G.L."/>
<person name="Matthews L."/>
<person name="McCann O.T."/>
<person name="McLaren S.J."/>
<person name="McLay K."/>
<person name="McMurray A."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Niblett D."/>
<person name="Nickerson T."/>
<person name="Novik K.L."/>
<person name="Oliver K."/>
<person name="Overton-Larty E.K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Phillips S."/>
<person name="Plumb R.W."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Ranby S.A."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Searle S.M."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Skuce C.D."/>
<person name="Smith S."/>
<person name="Smith M."/>
<person name="Spraggon L."/>
<person name="Squares S.L."/>
<person name="Steward C.A."/>
<person name="Sycamore N."/>
<person name="Tamlyn-Hall G."/>
<person name="Tester J."/>
<person name="Theaker A.J."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tubby B."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="White S.S."/>
<person name="Whitehead S.L."/>
<person name="Whittaker H."/>
<person name="Wild A."/>
<person name="Willey D.J."/>
<person name="Wilmer T.E."/>
<person name="Wood J.M."/>
<person name="Wray P.W."/>
<person name="Wyatt J.C."/>
<person name="Young L."/>
<person name="Younger R.M."/>
<person name="Bentley D.R."/>
<person name="Coulson A."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Sulston J.E."/>
<person name="Dunham I."/>
<person name="Rogers J."/>
<person name="Beck S."/>
</authorList>
<dbReference type="PubMed" id="14574404"/>
<dbReference type="DOI" id="10.1038/nature02055"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT SER-493</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1993" name="Nat. Genet." volume="3" first="260" last="265">
<title>A de novo pathological point mutation at the 21-hydroxylase locus: implications for gene conversion in the human genome.</title>
<authorList>
<person name="Collier S."/>
<person name="Tassabehji M."/>
<person name="Sinnott P."/>
<person name="Strachan T."/>
</authorList>
<dbReference type="PubMed" id="8485582"/>
<dbReference type="DOI" id="10.1038/ng0393-260"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 109-185</scope>
<scope>VARIANT AH3 ASN-172</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1985" name="Proc. Natl. Acad. Sci. U.S.A." volume="82" first="521" last="525">
<title>Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man.</title>
<authorList>
<person name="Carroll M.C."/>
<person name="Campbell R.D."/>
<person name="Porter R.R."/>
</authorList>
<dbReference type="PubMed" id="3871526"/>
<dbReference type="DOI" id="10.1073/pnas.82.2.521"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 149-182</scope>
<scope>VARIANT AH3 ASN-172</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1988" name="Proc. Natl. Acad. Sci. U.S.A." volume="85" first="1600" last="1604">
<title>Mutation in the CYP21B gene (Ile-172-->Asn) causes steroid 21-hydroxylase deficiency.</title>
<authorList>
<person name="Amor M."/>
<person name="Parker K.L."/>
<person name="Globerman H."/>
<person name="New M.I."/>
<person name="White P.C."/>
</authorList>
<dbReference type="PubMed" id="3257825"/>
<dbReference type="DOI" id="10.1073/pnas.85.5.1600"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 149-182</scope>
<scope>VARIANT AH3 ASN-172</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1987" name="Proc. Natl. Acad. Sci. U.S.A." volume="84" first="5858" last="5862">
<title>P450XXI (steroid 21-hydroxylase) gene deletions are not found in family studies of congenital adrenal hyperplasia.</title>
<authorList>
<person name="Matteson K.J."/>
<person name="Phillips J.A. III"/>
<person name="Miller W.L."/>
<person name="Chung B.C."/>
<person name="Orlando P.J."/>
<person name="Frisch H."/>
<person name="Ferrandez A."/>
<person name="Burr I.M."/>
</authorList>
<dbReference type="PubMed" id="3497399"/>
<dbReference type="DOI" id="10.1073/pnas.84.16.5858"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 265-494 (ISOFORM 1)</scope>
<scope>VARIANT AH3 LEU-281</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2015" name="J. Biol. Chem." volume="290" first="13128" last="13143">
<title>Human Cytochrome P450 21A2, the major steroid 21-hydroxylase: structure of the enzyme-progesterone substrate complex and rate-limiting c-h bond cleavage.</title>
<authorList>
<person name="Pallan P.S."/>
<person name="Wang C."/>
<person name="Lei L."/>
<person name="Yoshimoto F.K."/>
<person name="Auchus R.J."/>
<person name="Waterman M.R."/>
<person name="Guengerich F.P."/>
<person name="Egli M."/>
</authorList>
<dbReference type="PubMed" id="25855791"/>
<dbReference type="DOI" id="10.1074/jbc.M115.646307"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.64 ANGSTROMS) OF 29-494 IN COMPLEX WITH HEME AND PROGESTERONE</scope>
<scope>FUNCTION</scope>
<scope>COFACTOR</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1991" name="J. Clin. Invest." volume="88" first="519" last="523">
<title>Mutations of P450c21 (steroid 21-hydroxylase) at Cys428, Val281, and Ser268 result in complete, partial, or no loss of enzymatic activity, respectively.</title>
<authorList>
<person name="Wu D.-A."/>
<person name="Chung B.-C."/>
</authorList>
<dbReference type="PubMed" id="1864962"/>
<dbReference type="DOI" id="10.1172/JCI115334"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT AH3 LEU-281</scope>
<scope>MUTAGENESIS OF SER-268 AND CYS-428</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1993" name="Semin. Reprod. Endocrinol." volume="11" first="347" last="352">
<title>Molecular genetics of 21-hydroxylase deficient late-onset adrenal hyperplasia.</title>
<authorList>
<person name="Gunn S.K."/>
<person name="Sherman L.D."/>
<person name="Therrell B.L."/>
<person name="Owerbach D.I."/>
</authorList>
</citation>
<scope>REVIEW ON AH3 VARIANTS</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1994" name="Hum. Mutat." volume="3" first="373" last="378">
<title>Mutations in steroid 21-hydroxylase (CYP21).</title>
<authorList>
<person name="White P.C."/>
<person name="Tusie-Luna M.-T."/>
<person name="New M.I."/>
<person name="Speiser P.W."/>
</authorList>
<dbReference type="PubMed" id="8081391"/>
<dbReference type="DOI" id="10.1002/humu.1380030408"/>
</citation>
<scope>REVIEW ON AH3 VARIANTS</scope>
<scope>GENE CONVERSION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1988" name="N. Engl. J. Med." volume="319" first="19" last="23">
<title>Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14,DR1.</title>
<authorList>
<person name="Speiser P.W."/>
<person name="New M.I."/>
<person name="White P.C."/>
</authorList>
<dbReference type="PubMed" id="3260007"/>
<dbReference type="DOI" id="10.1056/NEJM198807073190104"/>
</citation>
<scope>VARIANTS AH3 LEU-211 AND LEU-281</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1990" name="J. Biol. Chem." volume="265" first="3549" last="3552">
<title>A missense mutation at Ile172-->Asn or Arg356-->Trp causes steroid 21-hydroxylase deficiency.</title>
<authorList>
<person name="Chiou S.-H."/>
<person name="Hu M.-C."/>
<person name="Chung B.-C."/>
</authorList>
<dbReference type="PubMed" id="2303461"/>
</citation>
<scope>VARIANTS AH3 ASN-172 AND TRP-356</scope>
<scope>VARIANT LEU-9 INS</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1991" name="Hum. Genet." volume="87" first="716" last="720">
<title>Substitution of Ile-172 to Asn in the steroid 21-hydroxylase B (P450c21B) gene in a Finnish patient with the simple virilizing form of congenital adrenal hyperplasia.</title>
<authorList>
<person name="Partanen J."/>
<person name="Campbell R.D."/>
</authorList>
<dbReference type="PubMed" id="1937474"/>
<dbReference type="DOI" id="10.1007/BF00201731"/>
</citation>
<scope>VARIANT AH3 ASN-172</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1991" name="Mol. Endocrinol." volume="5" first="685" last="692">
<title>A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele.</title>
<authorList>
<person name="Tusie-Luna M.T."/>
<person name="Speiser P.W."/>
<person name="Dumic M."/>
<person name="New M.I."/>
<person name="White P.C."/>
</authorList>
<dbReference type="PubMed" id="2072928"/>
<dbReference type="DOI" id="10.1210/mend-5-5-685"/>
</citation>
<scope>VARIANT AH3 LEU-30</scope>
<scope>VARIANT THR-268</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1992" name="J. Clin. Invest." volume="90" first="584" last="595">
<title>Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.</title>
<authorList>
<person name="Speiser P.W."/>
<person name="Dupont J."/>
<person name="Zhu D."/>
<person name="Serrat J."/>
<person name="Buegeleisen M."/>
<person name="Tusie-Luna M.-T."/>
<person name="Lesser M."/>
<person name="New M.I."/>
<person name="White P.C."/>
</authorList>
<dbReference type="PubMed" id="1644925"/>
<dbReference type="DOI" id="10.1172/JCI115897"/>
</citation>
<scope>VARIANTS AH3 LEU-30; ASN-172; ASN-236; GLU-237; LYS-239; LEU-281 AND TRP-356</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1992" name="Mol. Endocrinol." volume="6" first="1211" last="1215">
<title>Pro-453 to Ser mutation in CYP21 is associated with nonclassic steroid 21-hydroxylase deficiency.</title>
<authorList>
<person name="Owerbach D."/>
<person name="Sherman L."/>
<person name="Ballard A.L."/>
<person name="Azziz R."/>
</authorList>
<dbReference type="PubMed" id="1406699"/>
<dbReference type="DOI" id="10.1210/mend.6.8.1406699"/>
</citation>
<scope>VARIANT AH3 SER-453</scope>
</reference>
<reference key="25">
<citation type="journal article" date="1992" name="Proc. Natl. Acad. Sci. U.S.A." volume="89" first="7232" last="7236">
<title>Steroid 21-hydroxylase deficiency: three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations.</title>
<authorList>
<person name="Wedell A."/>
<person name="Ritzen E.M."/>
<person name="Haglund-Stengler B."/>
<person name="Luthman H."/>
</authorList>
<dbReference type="PubMed" id="1496017"/>
<dbReference type="DOI" id="10.1073/pnas.89.15.7232"/>
</citation>
<scope>VARIANTS AH3 LEU-105; SER-291 AND SER-453</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1993" name="Hum. Genet." volume="91" first="236" last="240">
<title>Steroid 21-hydroxylase (P450c21): a new allele and spread of mutations through the pseudogene.</title>
<authorList>
<person name="Wedell A."/>
<person name="Luthman H."/>
</authorList>
<dbReference type="PubMed" id="8478006"/>
<dbReference type="DOI" id="10.1007/BF00218263"/>
</citation>
<scope>VARIANT AH3 PRO-483</scope>
</reference>
<reference key="27">
<citation type="journal article" date="1995" name="Hum. Mutat." volume="5" first="126" last="130">
<title>Screening of CYP21 gene mutations in 129 French patients affected by steroid 21-hydroxylase deficiency.</title>
<authorList>
<person name="Barbat B."/>
<person name="Bogyo A."/>
<person name="Raux-Demay M.-C."/>
<person name="Kuttenn F."/>
<person name="Boue J."/>
<person name="Simon-Bouy B."/>
<person name="Serre J.-L."/>
<person name="Boue A."/>
<person name="Mornet E."/>
</authorList>
<dbReference type="PubMed" id="7749410"/>
<dbReference type="DOI" id="10.1002/humu.1380050205"/>
</citation>
<scope>VARIANTS AH3 ASN-172; ASN-236; LEU-281 AND PRO-483</scope>
<scope>VARIANT SER-493</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1997" name="Hum. Mutat." volume="9" first="181" last="182">
<title>E380D: a novel point mutation of CYP21 in an HLA-homozygous patient with salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency.</title>
<authorList>
<person name="Kirby-Keyser L."/>
<person name="Porter C.C."/>
<person name="Donohoue P.A."/>
</authorList>
<dbReference type="PubMed" id="9067760"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1997)9:2&lt;181::AID-HUMU12>3.0.CO;2-Z"/>
</citation>
<scope>VARIANT AH3 ASP-380</scope>
</reference>
<reference key="29">
<citation type="journal article" date="1997" name="Hum. Genet." volume="99" first="704" last="709">
<title>A cluster of missense mutations at Arg356 of human steroid 21-hydroxylase may impair redox partner interaction.</title>
<authorList>
<person name="Lajic S."/>
<person name="Levo A."/>
<person name="Nikoshkov A."/>
<person name="Lundberg Y."/>
<person name="Partanen J."/>
<person name="Wedell A."/>
</authorList>
<dbReference type="PubMed" id="9187661"/>
<dbReference type="DOI" id="10.1007/s004390050436"/>
</citation>
<scope>VARIANTS AH3 PRO-356 AND GLN-356</scope>
</reference>
<reference key="30">
<citation type="journal article" date="1997" name="J. Clin. Endocrinol. Metab." volume="82" first="194" last="199">
<title>Synergistic effect of partially inactivating mutations in steroid 21-hydroxylase deficiency.</title>
<authorList>
<person name="Nikoshkov A."/>
<person name="Lajic S."/>
<person name="Holst M."/>
<person name="Wedell A."/>
<person name="Luthman H."/>
</authorList>
<dbReference type="PubMed" id="8989258"/>
<dbReference type="DOI" id="10.1210/jcem.82.1.3678"/>
</citation>
<scope>VARIANTS AH3 LEU-105 AND SER-453</scope>
</reference>
<reference key="31">
<citation type="journal article" date="1998" name="Hum. Genet." volume="102" first="170" last="177">
<title>Molecular genetic analysis of patients carrying steroid 21-hydroxylase deficiency in the Mexican population: identification of possible new mutations and high prevalence of apparent germ-line mutations.</title>
<authorList>
<person name="Ordonez-Sanchez M.L."/>
<person name="Ramirez-Jimenez S."/>
<person name="Lopez-Gutierrez A.U."/>
<person name="Riba L."/>
<person name="Gamboa-Cardiel S."/>
<person name="Cerrillo-Hinojosa M."/>
<person name="Altamirano-Bustamante N."/>
<person name="Calzada-Leon R."/>
<person name="Robles-Valdes C."/>
<person name="Mendoza-Morfin F."/>
<person name="Tusie-Luna M.T."/>
</authorList>
<dbReference type="PubMed" id="9580109"/>
<dbReference type="DOI" id="10.1007/s004390050672"/>
</citation>
<scope>VARIANTS AH3</scope>
<scope>VARIANTS</scope>
</reference>
<reference key="32">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="6163" last="6165">
<title>Naturally occurring mutants of human steroid 21-hydroxylase (P450c21) pinpoint residues important for enzyme activity and stability.</title>
<authorList>
<person name="Nikoshkov A."/>
<person name="Lajic S."/>
<person name="Vlamis-Gardikas A."/>
<person name="Tranebjaerg L."/>
<person name="Holst M."/>
<person name="Wedell A."/>
<person name="Luthman H."/>
</authorList>
<dbReference type="PubMed" id="9497336"/>
<dbReference type="DOI" id="10.1074/jbc.273.11.6163"/>
</citation>
<scope>VARIANTS AH3 GLU-196 DEL; SER-291 AND PRO-483</scope>
</reference>
<reference key="33">
<citation type="journal article" date="1999" name="Biochem. Biophys. Res. Commun." volume="257" first="384" last="390">
<title>Effects of missense mutations and deletions on membrane anchoring and enzyme function of human steroid 21-hydroxylase (P450c21).</title>
<authorList>
<person name="Lajic S."/>
<person name="Nikoshkov A."/>
<person name="Holst M."/>
<person name="Wedell A."/>
</authorList>
<dbReference type="PubMed" id="10198222"/>
<dbReference type="DOI" id="10.1006/bbrc.1999.0482"/>
</citation>
<scope>VARIANT AH3 GLN-30</scope>
<scope>CHARACTERIZATION OF VARIANT AH3 GLN-30</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TOPOLOGY</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="34">
<citation type="journal article" date="1999" name="Hum. Hered." volume="49" first="169" last="175">
<title>Mutation analysis in patients with congenital adrenal hyperplasia in the Spanish population: identification of putative novel steroid 21-hydroxylase deficiency alleles associated with the classic form of the disease.</title>
<authorList>
<person name="Lobato M.N."/>
<person name="Ordonez-Sanchez M.L."/>
<person name="Tusie-Luna M.T."/>
<person name="Meseguer A."/>
</authorList>
<dbReference type="PubMed" id="10364682"/>
<dbReference type="DOI" id="10.1159/000022866"/>
</citation>
<scope>VARIANTS AH3 LEU-30; VAL-90; ASN-172; ALA-178; LEU-281; CYS-291; HIS-354; TRP-356 AND SER-453</scope>
</reference>
<reference key="35">
<citation type="journal article" date="1999" name="Hum. Mutat." volume="13" first="172" last="172">
<title>Identification of CYP21 mutations, one novel, by single strand conformational polymorphism (SSCP) analysis.</title>
<authorList>
<person name="Witchel S.F."/>
<person name="Smith R."/>
<person name="Suda-Hartman M."/>
</authorList>
<dbReference type="PubMed" id="10094562"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1999)13:2&lt;172::AID-HUMU17>3.3.CO;2-E"/>
</citation>
<scope>VARIANTS AH3 TYR-169; LEU-281 AND GLN-356</scope>
</reference>
<reference key="36">
<citation type="journal article" date="1999" name="Hum. Mutat." volume="13" first="482" last="486">
<title>Steroid 21-hydroxylase deficiency: mutational spectrum in Denmark, three novel mutations, and in vitro expression analysis.</title>
<authorList>
<person name="Ohlsson G."/>
<person name="Mueller J."/>
<person name="Skakkebaek N.E."/>
<person name="Schwartz M."/>
</authorList>
<dbReference type="PubMed" id="10408778"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1999)13:6&lt;482::AID-HUMU8>3.0.CO;2-0"/>
</citation>
<scope>VARIANTS AH3 LEU-30; GLU-64; ASN-172; ASN-236; LEU-281; SER-291; TRP-356 AND VAL-362</scope>
</reference>
<reference key="37">
<citation type="journal article" date="1999" name="Hum. Mutat." volume="13" first="505" last="505">
<title>A rapid screening for steroid 21-hydroxylase mutations in patients with congenital adrenal hyperplasia.</title>
<authorList>
<person name="Kapelari K."/>
<person name="Ghanaati Z."/>
<person name="Wollmann H."/>
<person name="Ventz M."/>
<person name="Ranke M.B."/>
<person name="Kofler R."/>
<person name="Peters H."/>
</authorList>
<dbReference type="PubMed" id="10408786"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1999)13:6&lt;505::AID-HUMU16>3.0.CO;2-0"/>
</citation>
<scope>VARIANTS AH3 LEU-30; ASN-172; ASN-236; GLU-237; LYS-239; LEU-281 AND TRP-356</scope>
</reference>
<reference key="38">
<citation type="journal article" date="1999" name="J. Clin. Endocrinol. Metab." volume="84" first="2870" last="2872">
<title>A novel missense mutation, GLY424SER, in Brazilian patients with 21-hydroxylase deficiency.</title>
<authorList>
<person name="Billerbeck A.E.C."/>
<person name="Bachega T.A.S.S."/>
<person name="Frazatto E.T."/>
<person name="Nishi M.Y."/>
<person name="Goldberg A.C."/>
<person name="Marin M.L.C."/>
<person name="Madureira G."/>
<person name="Monte O."/>
<person name="Arnhold I.J.P."/>
<person name="Mendonca B.B."/>
</authorList>
<dbReference type="PubMed" id="10443693"/>
<dbReference type="DOI" id="10.1210/jcem.84.8.5937"/>
</citation>
<scope>VARIANTS AH3 LEU-281; TRP-356 AND SER-424</scope>
</reference>
<reference key="39">
<citation type="journal article" date="1999" name="J. Hum. Genet." volume="44" first="312" last="317">
<title>Molecular analysis of Japanese patients with steroid 21-hydroxylase deficiency.</title>
<authorList>
<person name="Asanuma A."/>
<person name="Ohura T."/>
<person name="Ogawa E."/>
<person name="Sato S."/>
<person name="Igarashi Y."/>
<person name="Matsubara Y."/>
<person name="Iinuma K."/>
</authorList>
<dbReference type="PubMed" id="10496074"/>
<dbReference type="DOI" id="10.1007/s100380050167"/>
</citation>
<scope>VARIANTS AH3 LEU-30; ASN-172; LEU-281; TRP-356 AND SER-493</scope>
<scope>VARIANT THR-268</scope>
</reference>
<reference key="40">
<citation type="journal article" date="1999" name="J. Med. Genet." volume="36" first="119" last="124">
<title>Mutation screening in British 21-hydroxylase deficiency families and development of novel microsatellite based approaches to prenatal diagnosis.</title>
<authorList>
<person name="Lako M."/>
<person name="Ramsden S."/>
<person name="Campbell R.D."/>
<person name="Strachan T."/>
</authorList>
<dbReference type="PubMed" id="10051010"/>
</citation>
<scope>VARIANTS AH3 ASN-172 AND TRP-356</scope>
</reference>
<reference key="41">
<citation type="journal article" date="1999" name="Nat. Genet." volume="22" first="231" last="238">
<title>Characterization of single-nucleotide polymorphisms in coding regions of human genes.</title>
<authorList>
<person name="Cargill M."/>
<person name="Altshuler D."/>
<person name="Ireland J."/>
<person name="Sklar P."/>
<person name="Ardlie K."/>
<person name="Patil N."/>
<person name="Shaw N."/>
<person name="Lane C.R."/>
<person name="Lim E.P."/>
<person name="Kalyanaraman N."/>
<person name="Nemesh J."/>
<person name="Ziaugra L."/>
<person name="Friedland L."/>
<person name="Rolfe A."/>
<person name="Warrington J."/>
<person name="Lipshutz R."/>
<person name="Daley G.Q."/>
<person name="Lander E.S."/>
</authorList>
<dbReference type="PubMed" id="10391209"/>
<dbReference type="DOI" id="10.1038/10290"/>
</citation>
<scope>VARIANTS AH3 LEU-281 AND SER-453</scope>
<scope>VARIANTS THR-268 AND SER-493</scope>
</reference>
<reference key="42">
<citation type="journal article" date="1999" name="Nat. Genet." volume="23" first="373" last="373">
<authorList>
<person name="Cargill M."/>
<person name="Altshuler D."/>
<person name="Ireland J."/>
<person name="Sklar P."/>
<person name="Ardlie K."/>
<person name="Patil N."/>
<person name="Shaw N."/>
<person name="Lane C.R."/>
<person name="Lim E.P."/>
<person name="Kalyanaraman N."/>
<person name="Nemesh J."/>
<person name="Ziaugra L."/>
<person name="Friedland L."/>
<person name="Rolfe A."/>
<person name="Warrington J."/>
<person name="Lipshutz R."/>
<person name="Daley G.Q."/>
<person name="Lander E.S."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2000" name="J. Clin. Endocrinol. Metab." volume="85" first="1059" last="1065">
<title>Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany.</title>
<authorList>
<person name="Krone N."/>
<person name="Braun A."/>
<person name="Roscher A.A."/>
<person name="Knorr D."/>
<person name="Schwarz H.P."/>
</authorList>
<dbReference type="PubMed" id="10720040"/>
<dbReference type="DOI" id="10.1210/jcem.85.3.6441"/>
</citation>
<scope>VARIANTS AH3 LEU-30; ASN-172; LEU-281; GLY-281; PHE-300; CYS-354; TRP-356 AND SER-453</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2001" name="Horm. Res." volume="55" first="179" last="184">
<title>Molecular analysis of CYP-21 mutations for congenital adrenal hyperplasia in Singapore.</title>
<authorList>
<person name="Loke K.Y."/>
<person name="Lee Y.S."/>
<person name="Lee W.W.R."/>
<person name="Poh L.K.S."/>
</authorList>
<dbReference type="PubMed" id="11598371"/>
<dbReference type="DOI" id="10.1159/000049992"/>
</citation>
<scope>VARIANTS AH3 LEU-30; ASN-172; PRO-261; TRP-356 AND PRO-483</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2001" name="J. Clin. Endocrinol. Metab." volume="86" first="207" last="213">
<title>Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.</title>
<authorList>
<person name="Deneux C."/>
<person name="Tardy V."/>
<person name="Dib A."/>
<person name="Mornet E."/>
<person name="Billaud L."/>
<person name="Charron D."/>
<person name="Morel Y."/>
<person name="Kuttenn F."/>
</authorList>
<dbReference type="PubMed" id="11232002"/>
<dbReference type="DOI" id="10.1210/jcem.86.1.7131"/>
</citation>
<scope>VARIANTS AH3 LEU-30; ASN-172; LEU-281; MET-317; TRP-356; CYS-435 AND SER-453</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2001" name="J. Clin. Endocrinol. Metab." volume="86" first="4771" last="4775">
<title>Mutational spectrum of the steroid 21-hydroxylase gene in Austria: identification of a novel missense mutation.</title>
<authorList>
<person name="Baumgartner-Parzer S.M."/>
<person name="Schulze E."/>
<person name="Waldhaeusl W."/>
<person name="Pauschenwein S."/>
<person name="Rondot S."/>
<person name="Nowotny P."/>
<person name="Meyer K."/>
<person name="Frisch H."/>
<person name="Waldhauser F."/>
<person name="Vierhapper H."/>
</authorList>
<dbReference type="PubMed" id="11600539"/>
<dbReference type="DOI" id="10.1210/jcem.86.10.7898"/>
</citation>
<scope>VARIANTS AH3 LEU-30; ASN-172; LEU-281; SER-291; TRP-356; SER-424; HIS-426; SER-453 AND PRO-483</scope>
<scope>CHARACTERIZATION OF VARIANT AH3 HIS-426</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2001" name="Prenat. Diagn." volume="21" first="885" last="889">
<title>Novel mutations in the human CYP21 gene.</title>
<authorList>
<person name="Levo A."/>
<person name="Partanen J."/>
</authorList>
<dbReference type="PubMed" id="11746135"/>
<dbReference type="DOI" id="10.1002/pd.167"/>
</citation>
<scope>VARIANT AH3 TRP-363</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2002" name="Acta Paediatr." volume="91" first="892" last="898">
<title>Non-classical 21-hydroxylase deficiency in children: association of adrenocorticotropic hormone-stimulated 17-hydroxyprogesterone with the risk of compound heterozygosity with severe mutations.</title>
<authorList>
<person name="Ezquieta B."/>
<person name="Cueva E."/>
<person name="Varela J."/>
<person name="Oliver A."/>
<person name="Fernandez J."/>
<person name="Jariego C."/>
</authorList>
<dbReference type="PubMed" id="12222711"/>
<dbReference type="DOI" id="10.1080/080352502760148595"/>
</citation>
<scope>VARIANTS AH3 LEU-30; ASN-172; LEU-281; LEU-283; TRP-356 AND SER-453</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2002" name="J. Clin. Endocrinol. Metab." volume="87" first="2824" last="2829">
<title>Novel mutations in CYP21 detected in individuals with hyperandrogenism.</title>
<authorList>
<person name="Lajic S."/>
<person name="Clauin S."/>
<person name="Robins T."/>
<person name="Vexiau P."/>
<person name="Blanche H."/>
<person name="Bellanne-Chantelot C."/>
<person name="Wedell A."/>
</authorList>
<dbReference type="PubMed" id="12050257"/>
<dbReference type="DOI" id="10.1210/jcem.87.6.8525"/>
</citation>
<scope>VARIANTS HYPERANDROGENISM MET-304; SER-375 AND SER-453</scope>
<scope>CHARACTERIZATION OF VARIANTS HYPERANDROGENISM MET-304; SER-375 AND SER-453</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2002" name="J. Clin. Endocrinol. Metab." volume="87" first="4314" last="4317">
<title>Three novel mutations in CYP21 gene in Brazilian patients with the classical form of 21-hydroxylase deficiency due to a founder effect.</title>
<authorList>
<person name="Billerbeck A.E.C."/>
<person name="Mendonca B.B."/>
<person name="Pinto E.M."/>
<person name="Madureira G."/>
<person name="Arnhold I.J.P."/>
<person name="Bachega T.A.S.S."/>
</authorList>
<dbReference type="PubMed" id="12213891"/>
<dbReference type="DOI" id="10.1210/jc.2001-011939"/>
</citation>
<scope>VARIANTS AH3 CYS-408 AND SER-424</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2003" name="Eur. J. Endocrinol." volume="149" first="137" last="144">
<title>Mutational spectrum of congenital adrenal hyperplasia in Slovenian patients: a novel Ala15Thr mutation and Pro30Leu within a larger gene conversion associated with a severe form of the disease.</title>
<authorList>
<person name="Dolzan V."/>
<person name="Stopar-Obreza M."/>
<person name="Zerjav-Tansek M."/>
<person name="Breskvar K."/>
<person name="Krzisnik C."/>
<person name="Battelino T."/>
</authorList>
<dbReference type="PubMed" id="12887291"/>
<dbReference type="DOI" id="10.1530/eje.0.1490137"/>
</citation>
<scope>VARIANTS AH3 THR-15; LEU-30; ASN-172; LEU-281 AND SER-453</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2003" name="J. Clin. Endocrinol. Metab." volume="88" first="2624" last="2633">
<title>Follow-up of 68 children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: relevance of genotype for management.</title>
<authorList>
<person name="Pinto G."/>
<person name="Tardy V."/>
<person name="Trivin C."/>
<person name="Thalassinos C."/>
<person name="Lortat-Jacob S."/>
<person name="Nihoul-Fekete C."/>
<person name="Morel Y."/>
<person name="Brauner R."/>
</authorList>
<dbReference type="PubMed" id="12788866"/>
<dbReference type="DOI" id="10.1210/jc.2002-021433"/>
</citation>
<scope>VARIANTS AH3 LEU-30; LEU-62; ASN-172; LEU-281; PRO-341; TRP-356; SER-453 AND PRO-483</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2003" name="J. Clin. Endocrinol. Metab." volume="88" first="3852" last="3859">
<title>CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations.</title>
<authorList>
<person name="Stikkelbroeck N.M."/>
<person name="Hoefsloot L.H."/>
<person name="de Wijs I.J."/>
<person name="Otten B.J."/>
<person name="Hermus A.R."/>
<person name="Sistermans E.A."/>
</authorList>
<dbReference type="PubMed" id="12915679"/>
<dbReference type="DOI" id="10.1210/jc.2002-021681"/>
</citation>
<scope>VARIANTS AH3 ASN-172; LEU-281; ARG-291; TYR-301; PRO-341; TRP-356 AND GLN-483</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2004" name="J. Clin. Endocrinol. Metab." volume="89" first="368" last="374">
<title>Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation.</title>
<authorList>
<person name="Kharrat M."/>
<person name="Tardy V."/>
<person name="M'Rad R."/>
<person name="Maazoul F."/>
<person name="Jemaa L.B."/>
<person name="Refai M."/>
<person name="Morel Y."/>
<person name="Chaabouni H."/>
</authorList>
<dbReference type="PubMed" id="14715874"/>
<dbReference type="DOI" id="10.1210/jc.2003-031056"/>
</citation>
<scope>VARIANTS AH3 ASN-172; TRP-356 AND TRP-483</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2004" name="Horm. Res." volume="61" first="126" last="132">
<title>Three novel mutations in Japanese patients with 21-hydroxylase deficiency.</title>
<authorList>
<person name="Usui T."/>
<person name="Nishisho K."/>
<person name="Kaji M."/>
<person name="Ikuno N."/>
<person name="Yorifuji T."/>
<person name="Yasuda T."/>
<person name="Kuzuya H."/>
<person name="Shimatsu A."/>
</authorList>
<dbReference type="PubMed" id="14676460"/>
<dbReference type="DOI" id="10.1159/000075587"/>
</citation>
<scope>VARIANT AH3 HIS-124</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2004" name="J. Clin. Endocrinol. Metab." volume="89" first="2402" last="2407">
<title>Functional analysis of two recurrent amino acid substitutions in the CYP21 gene from Italian patients with congenital adrenal hyperplasia.</title>
<authorList>
<person name="Barbaro M."/>
<person name="Lajic S."/>
<person name="Baldazzi L."/>
<person name="Balsamo A."/>
<person name="Pirazzoli P."/>
<person name="Cicognani A."/>
<person name="Wedell A."/>
<person name="Cacciari E."/>
</authorList>
<dbReference type="PubMed" id="15126570"/>
<dbReference type="DOI" id="10.1210/jc.2003-031630"/>
</citation>
<scope>VARIANTS AH3 THR-15; LEU-30; LEU-281 AND SER-482</scope>
<scope>CHARACTERIZATION OF VARIANTS AH3 THR-15 AND SER-482</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2004" name="Mol. Genet. Metab." volume="82" first="38" last="47">
<title>Detection and assignment of CYP21 mutations using peptide mass signature genotyping.</title>
<authorList>
<person name="Zeng X."/>
<person name="Witchel S.F."/>
<person name="Dobrowolski S.F."/>
<person name="Moulder P.V."/>
<person name="Jarvik J.W."/>
<person name="Telmer C.A."/>
</authorList>
<dbReference type="PubMed" id="15110320"/>
<dbReference type="DOI" id="10.1016/j.ymgme.2004.02.006"/>
</citation>
<scope>VARIANTS AH3 LEU-30; ASN-172; ASN-236; GLU-237; LYS-239; LEU-281; SER-291; GLN-356; TRP-356; TYR-365; SER-453; LEU-479 AND PRO-483</scope>
<scope>VARIANT ARG-102</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2005" name="J. Clin. Endocrinol. Metab." volume="90" first="5769" last="5773">
<title>21-Hydroxylase and 11beta-hydroxylase mutations in Romanian patients with classic congenital adrenal hyperplasia.</title>
<authorList>
<person name="Grigorescu Sido A."/>
<person name="Weber M.M."/>
<person name="Grigorescu Sido P."/>
<person name="Clausmeyer S."/>
<person name="Heinrich U."/>
<person name="Schulze E."/>
</authorList>
<dbReference type="PubMed" id="16046588"/>
<dbReference type="DOI" id="10.1210/jc.2005-0379"/>
</citation>
<scope>VARIANTS AH3 LEU-30; ASN-172 AND TRP-356</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2006" name="J. Clin. Endocrinol. Metab." volume="91" first="4976" last="4980">
<title>Four novel missense mutations in the CYP21A2 gene detected in Russian patients suffering from the classical form of congenital adrenal hyperplasia: identification, functional characterization, and structural analysis.</title>
<authorList>
<person name="Grischuk Y."/>
<person name="Rubtsov P."/>
<person name="Riepe F.G."/>
<person name="Groetzinger J."/>
<person name="Beljelarskaia S."/>
<person name="Prassolov V."/>
<person name="Kalintchenko N."/>
<person name="Semitcheva T."/>
<person name="Peterkova V."/>
<person name="Tiulpakov A."/>
<person name="Sippell W.G."/>
<person name="Krone N."/>
</authorList>
<dbReference type="PubMed" id="16984992"/>
<dbReference type="DOI" id="10.1210/jc.2006-0777"/>
</citation>
<scope>VARIANTS AH3 ARG-169; ARG-178; ARG-302 AND CYS-426</scope>
<scope>CHARACTERIZATION OF VARIANTS AH3 ARG-169; ARG-178; ARG-302; CYS-426 AND HIS-426</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2008" name="J. Clin. Endocrinol. Metab." volume="93" first="1901" last="1908">
<title>p.H62L, a rare mutation of the CYP21 gene identified in two forms of 21-hydroxylase deficiency.</title>
<authorList>
<person name="Menassa R."/>
<person name="Tardy V."/>
<person name="Despert F."/>
<person name="Bouvattier-Morel C."/>
<person name="Brossier J.P."/>
<person name="Cartigny M."/>
<person name="Morel Y."/>
</authorList>
<dbReference type="PubMed" id="18319307"/>
<dbReference type="DOI" id="10.1210/jc.2007-2701"/>
</citation>
<scope>VARIANTS AH3 LEU-30; LEU-62; ASN-172; TRP-356 AND SER-453</scope>
<scope>CHARACTERIZATION OF VARIANTS AH3 LEU-62 AND SER-453</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2008" name="J. Clin. Endocrinol. Metab." volume="93" first="2416" last="2420">
<title>Inhibition of CYP21A2 enzyme activity caused by novel missense mutations identified in Brazilian and Scandinavian patients.</title>
<authorList>
<person name="Soardi F.C."/>
<person name="Barbaro M."/>
<person name="Lau I.F."/>
<person name="Lemos-Marini S.H."/>
<person name="Baptista M.T."/>
<person name="Guerra-Junior G."/>
<person name="Wedell A."/>
<person name="Lajic S."/>
<person name="de Mello M.P."/>
</authorList>
<dbReference type="PubMed" id="18381579"/>
<dbReference type="DOI" id="10.1210/jc.2007-2594"/>
</citation>
<scope>VARIANTS AH3 ARG-56; LEU-62; ARG-107; PRO-142; ASN-172; TRP-356; CYS-408 AND SER-453</scope>
<scope>CHARACTERIZATION OF VARIANTS AH3 ARG-56; LEU-62; ARG-107; PRO-142; CYS-408 AND SER-453</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2008" name="J. Clin. Endocrinol. Metab." volume="93" first="2891" last="2895">
<title>Functional and structural consequences of a novel point mutation in the CYP21A2 gene causing congenital adrenal hyperplasia: potential relevance of helix C for P450 oxidoreductase-21-hydroxylase interaction.</title>
<authorList>
<person name="Riepe F.G."/>
<person name="Hiort O."/>
<person name="Grotzinger J."/>
<person name="Sippell W.G."/>
<person name="Krone N."/>
<person name="Holterhus P.M."/>
</authorList>
<dbReference type="PubMed" id="18445671"/>
<dbReference type="DOI" id="10.1210/jc.2007-2646"/>
</citation>
<scope>VARIANTS AH3 GLN-121 AND SER-453</scope>
<scope>CHARACTERIZATION OF VARIANT AH3 GLN-121</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2010" name="J. Clin. Endocrinol. Metab." volume="95" first="1288" last="1300">
<title>Phenotype-genotype correlations of 13 rare CYP21A2 mutations detected in 46 patients affected with 21-hydroxylase deficiency and in one carrier.</title>
<authorList>
<person name="Tardy V."/>
<person name="Menassa R."/>
<person name="Sulmont V."/>
<person name="Lienhardt-Roussie A."/>
<person name="Lecointre C."/>
<person name="Brauner R."/>
<person name="David M."/>
<person name="Morel Y."/>
</authorList>
<dbReference type="PubMed" id="20080860"/>
<dbReference type="DOI" id="10.1210/jc.2009-1202"/>
</citation>
<scope>VARIANTS AH3 THR-77; PRO-167; ASN-172; THR-230; LYS-233; LEU-281; SER-291; ASP-292; LYS-320; PRO-341; HIS-354; TRP-356; TRP-369; CYS-408; SER-424; HIS-426 AND SER-453</scope>
<scope>CHARACTERIZATION OF VARIANTS AH3 PRO-167; ASN-172; LEU-281; ASP-292; LYS-320; TRP-369 AND SER-424</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2011" name="J. Endocrinol. Invest." volume="34" first="847" last="854">
<title>A large view of CYP21 locus among Sicilians and other populations: identification of a novel CYP21A2 variant in Sicily.</title>
<authorList>
<person name="Niceta M."/>
<person name="Bono M."/>
<person name="Fabiano C."/>
<person name="Pojero F."/>
<person name="Niceta F."/>
<person name="Sammarco P."/>
<person name="Corsello G."/>
<person name="Garofalo P."/>
</authorList>
<dbReference type="PubMed" id="21169732"/>
<dbReference type="DOI" id="10.3275/7417"/>
</citation>
<scope>VARIANT AH3 PHE-198</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2012" name="Metabolism" volume="61" first="519" last="524">
<title>p.H282N and p.Y191H: 2 novel CYP21A2 mutations in Italian congenital adrenal hyperplasia patients.</title>
<authorList>
<person name="Concolino P."/>
<person name="Mello E."/>
<person name="Patrosso M.C."/>
<person name="Penco S."/>
<person name="Zuppi C."/>
<person name="Capoluongo E."/>
</authorList>
<dbReference type="PubMed" id="22014889"/>
<dbReference type="DOI" id="10.1016/j.metabol.2011.08.008"/>
</citation>
<scope>VARIANTS AH3 HIS-191 AND ASN-282</scope>
<scope>CHARACTERIZATION OF VARIANTS AH3 HIS-191 AND ASN-282</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2016" name="Int. J. Endocrinol." volume="2016" first="4209670" last="4209670">
<title>Functional and structural consequences of nine CYP21A2 mutations ranging from very mild to severe effects.</title>
<authorList>
<person name="de Paula Michelatto D."/>
<person name="Karlsson L."/>
<person name="Lusa A.L."/>
<person name="Silva C.D."/>
<person name="Oestberg L.J."/>
<person name="Persson B."/>
<person name="Guerra-Junior G."/>
<person name="de Lemos-Marini S.H."/>
<person name="Barbaro M."/>
<person name="de Mello M.P."/>
<person name="Lajic S."/>
</authorList>
<dbReference type="PubMed" id="27721825"/>
<dbReference type="DOI" id="10.1155/2016/4209670"/>
</citation>
<scope>VARIANTS AH3 MET-12; PHE-113; 389-GLN--ALA-391 DEL AND PRO-450</scope>
<scope>VARIANTS CYS-16; GLY-202; LEU-267 AND MET-450</scope>
<scope>CHARACTERIZATION OF VARIANTS AH3 MET-12; PHE-113; 389-GLN--ALA-391 DEL; PRO-450 AND SER-482</scope>
<scope>CHARACTERIZATION OF VARIANTS CYS-16; GLY-202; LEU-267 AND MET-450</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<comment type="function">
<text evidence="42 44 45">Specifically catalyzes the 21-hydroxylation of steroids. Required for the adrenal synthesis of mineralocorticoids and glucocorticoids (PubMed:22014889).</text>
</comment>
<comment type="catalytic activity">
<text evidence="33 42 44 45">A C(21) steroid + [reduced NADPH--hemoprotein reductase] + O(2) = a 21-hydroxy-C(21)-steroid + [oxidized NADPH--hemoprotein reductase] + H(2)O.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="44">
<name>heme</name>
<dbReference type="ChEBI" id="CHEBI:30413"/>
</cofactor>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="42">1.59 uM for 17-hydroxyprogesterone</KM>
<KM evidence="45">12.5 uM for for 17-hydroxyprogesterone (at 37 degrees Celsius)</KM>
<KM evidence="42">1.05 uM for progesterone</KM>
<Vmax evidence="42">5.8 nmol/min/mg enzyme</Vmax>
<Vmax evidence="45">0.5 nmol/min/mg enzyme (at 37 degrees Celsius)</Vmax>
</kinetics>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Endoplasmic reticulum membrane</location>
<topology evidence="5">Peripheral membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="5">Microsome membrane</location>
<topology evidence="5">Peripheral membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P08686-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P08686-2</id>
<name>2</name>
<sequence type="described" ref="VSP_046264 VSP_046265"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="domain">
<text evidence="5">The leucine-rich hydrophobic amino acid N-terminal region probably helps to anchor the protein to the microsomal membrane.</text>
</comment>
<comment type="polymorphism">
<text>Seven non deleterious alleles are known: CYP21A2*1A, CYP21A2*1B, CYP21A2*2, CYP21A2*3, CYP21A2*4, CYP21A2*5 and CYP21A2*6. The sequence shown corresponds to allele CYP21A2*1B. Deleterious alleles are mostly generated by recombinations between CYP21A2 and the pseudogene CYP21A1P through gene conversion. This process consists of recombination events that either delete CYP21A2 or transfer deleterious mutations from CYP21A1P to CYP21A2.</text>
</comment>
<comment type="disease" evidence="3 4 5 6 7 8 9 10 11 12 13 14 15 16 18 19 20 21 22 23 24 25 26 27 28 29 31 32 33 34 35 36 37 38 39 40 41 42 43 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59">
<disease id="DI-00043">
<name>Adrenal hyperplasia 3</name>
<acronym>AH3</acronym>
<description>A form of congenital adrenal hyperplasia, a common recessive disease due to defective synthesis of cortisol. Congenital adrenal hyperplasia is characterized by androgen excess leading to ambiguous genitalia in affected females, rapid somatic growth during childhood in both sexes with premature closure of the epiphyses and short adult stature. Four clinical types: 'salt wasting' (SW, the most severe type), 'simple virilizing' (SV, less severely affected patients), with normal aldosterone biosynthesis, 'non-classic form' or late-onset (NC or LOAH) and 'cryptic' (asymptomatic).</description>
<dbReference type="MIM" id="201910"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="61">Belongs to the cytochrome P450 family.</text>
</comment>
<comment type="online information" name="Cytochrome P450 Allele Nomenclature Committee">
<link uri="http://www.cypalleles.ki.se/cyp21.htm"/>
<text>CYP21A2 alleles</text>
</comment>
<comment type="online information" name="SHMPD">
<link uri="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&amp;genename=CYP21A2"/>
<text>The Singapore human mutation and polymorphism database</text>
</comment>
<dbReference type="EC" id="1.14.14.16" evidence="33 42 44 45"/>
<dbReference type="EMBL" id="M12792">
<property type="protein sequence ID" value="AAB59440.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M13936">
<property type="protein sequence ID" value="AAA59695.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M26856">
<property type="protein sequence ID" value="AAA52064.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X58906">
<property type="protein sequence ID" value="CAA41709.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="GQ222286">
<property type="protein sequence ID" value="ACT35412.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="GQ222296">
<property type="protein sequence ID" value="ACT35422.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="GQ222301">
<property type="protein sequence ID" value="ACT35427.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK054616">
<property type="protein sequence ID" value="BAB70774.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL645922">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL662828">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL662849">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL844853">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL929593">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BX679671">
<property type="protein sequence ID" value="CAM26070.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CR753845">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471081">
<property type="protein sequence ID" value="EAX03570.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CR936924">
<property type="protein sequence ID" value="CAQ07659.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC125182">
<property type="protein sequence ID" value="AAI25183.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="K02771">
<property type="protein sequence ID" value="AAA59706.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M19711">
<property type="protein sequence ID" value="AAA83248.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M17252">
<property type="protein sequence ID" value="AAA59985.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS47406.1">
<molecule id="P08686-2"/>
</dbReference>
<dbReference type="PIR" id="A25446">
<property type="entry name" value="O4HUC2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000491.4">
<property type="nucleotide sequence ID" value="NM_000500.7"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001122062.3">
<property type="nucleotide sequence ID" value="NM_001128590.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.654479"/>
<dbReference type="PDB" id="2GEG">
<property type="method" value="Model"/>
<property type="chains" value="C=27-494"/>
</dbReference>
<dbReference type="PDB" id="4Y8W">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.64"/>
<property type="chains" value="A/B/C=29-494"/>
</dbReference>
<dbReference type="PDBsum" id="2GEG"/>
<dbReference type="PDBsum" id="4Y8W"/>
<dbReference type="ProteinModelPortal" id="P08686"/>
<dbReference type="SMR" id="P08686"/>
<dbReference type="STRING" id="9606.ENSP00000408860"/>
<dbReference type="BindingDB" id="P08686"/>
<dbReference type="ChEMBL" id="CHEMBL2759"/>
<dbReference type="DrugBank" id="DB01026">
<property type="generic name" value="Ketoconazole"/>
</dbReference>
<dbReference type="SwissLipids" id="SLP:000001618"/>
<dbReference type="iPTMnet" id="P08686"/>
<dbReference type="PhosphoSitePlus" id="P08686"/>
<dbReference type="BioMuta" id="CYP21A2"/>
<dbReference type="DMDM" id="117275"/>
<dbReference type="PaxDb" id="P08686"/>
<dbReference type="PeptideAtlas" id="P08686"/>
<dbReference type="PRIDE" id="P08686"/>
<dbReference type="Ensembl" id="ENST00000383321">
<property type="protein sequence ID" value="ENSP00000372811"/>
<property type="gene ID" value="ENSG00000206338"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000434026">
<property type="protein sequence ID" value="ENSP00000392321"/>
<property type="gene ID" value="ENSG00000232414"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000435122">
<property type="protein sequence ID" value="ENSP00000415043"/>
<property type="gene ID" value="ENSG00000231852"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000436607">
<molecule id="P08686-1"/>
<property type="protein sequence ID" value="ENSP00000403721"/>
<property type="gene ID" value="ENSG00000235134"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000448314">
<molecule id="P08686-1"/>
<property type="protein sequence ID" value="ENSP00000398594"/>
<property type="gene ID" value="ENSG00000198457"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000452386">
<property type="protein sequence ID" value="ENSP00000403230"/>
<property type="gene ID" value="ENSG00000233151"/>
</dbReference>
<dbReference type="GeneID" id="1589"/>
<dbReference type="KEGG" id="hsa:1589"/>
<dbReference type="UCSC" id="uc003nzf.3">
<molecule id="P08686-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1589"/>
<dbReference type="DisGeNET" id="1589"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000231852.6"/>
<dbReference type="GeneCards" id="CYP21A2"/>
<dbReference type="H-InvDB" id="HIX0057724"/>
<dbReference type="H-InvDB" id="HIX0166983"/>
<dbReference type="HGNC" id="HGNC:2600">
<property type="gene designation" value="CYP21A2"/>
</dbReference>
<dbReference type="HPA" id="HPA048979"/>
<dbReference type="HPA" id="HPA053371"/>
<dbReference type="MalaCards" id="CYP21A2"/>
<dbReference type="MIM" id="201910">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="613815">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P08686"/>
<dbReference type="Orphanet" id="315306">
<property type="disease" value="Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form"/>
</dbReference>
<dbReference type="Orphanet" id="315311">
<property type="disease" value="Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form"/>
</dbReference>
<dbReference type="Orphanet" id="95698">
<property type="disease" value="Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency"/>
</dbReference>
<dbReference type="PharmGKB" id="PA27096"/>
<dbReference type="eggNOG" id="KOG0156">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG2124">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="HOGENOM" id="HOG000036991"/>
<dbReference type="HOVERGEN" id="HBG106944"/>
<dbReference type="InParanoid" id="P08686"/>
<dbReference type="KO" id="K00513"/>
<dbReference type="OrthoDB" id="EOG091G074I"/>
<dbReference type="PhylomeDB" id="P08686"/>
<dbReference type="BioCyc" id="MetaCyc:HS09769-MONOMER"/>
<dbReference type="BRENDA" id="1.14.99.10">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-193993">
<property type="pathway name" value="Mineralocorticoid biosynthesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-194002">
<property type="pathway name" value="Glucocorticoid biosynthesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-211976">
<property type="pathway name" value="Endogenous sterols"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5579021">
<property type="pathway name" value="Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)"/>
</dbReference>
<dbReference type="GeneWiki" id="21-Hydroxylase"/>
<dbReference type="GenomeRNAi" id="1589"/>
<dbReference type="PRO" id="PR:P08686"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 6"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000231852"/>
<dbReference type="CleanEx" id="HS_CYP21A2"/>
<dbReference type="ExpressionAtlas" id="P08686">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P08686">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031090">
<property type="term" value="C:organelle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0020037">
<property type="term" value="F:heme binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005506">
<property type="term" value="F:iron ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0004509">
<property type="term" value="F:steroid 21-monooxygenase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005496">
<property type="term" value="F:steroid binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008395">
<property type="term" value="F:steroid hydroxylase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006704">
<property type="term" value="P:glucocorticoid biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006705">
<property type="term" value="P:mineralocorticoid biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006694">
<property type="term" value="P:steroid biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008202">
<property type="term" value="P:steroid metabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016125">
<property type="term" value="P:sterol metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.630.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR001128">
<property type="entry name" value="Cyt_P450"/>
</dbReference>
<dbReference type="InterPro" id="IPR017972">
<property type="entry name" value="Cyt_P450_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR002401">
<property type="entry name" value="Cyt_P450_E_grp-I"/>
</dbReference>
<dbReference type="InterPro" id="IPR036396">
<property type="entry name" value="Cyt_P450_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF00067">
<property type="entry name" value="p450"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00463">
<property type="entry name" value="EP450I"/>
</dbReference>
<dbReference type="PRINTS" id="PR00385">
<property type="entry name" value="P450"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48264">
<property type="entry name" value="SSF48264"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00086">
<property type="entry name" value="CYTOCHROME_P450"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0954">Congenital adrenal hyperplasia</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0349">Heme</keyword>
<keyword id="KW-0408">Iron</keyword>
<keyword id="KW-0446">Lipid-binding</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0492">Microsome</keyword>
<keyword id="KW-0503">Monooxygenase</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0754">Steroid-binding</keyword>
<keyword id="KW-0755">Steroidogenesis</keyword>
<feature type="chain" description="Steroid 21-hydroxylase" id="PRO_0000051976">
<location>
<begin position="1"/>
<end position="494"/>
</location>
</feature>
<feature type="region of interest" description="Steroid-binding" evidence="2">
<location>
<begin position="342"/>
<end position="358"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Iron (heme axial ligand)" evidence="44">
<location>
<position position="428"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="44">
<location>
<position position="233"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_046264" evidence="60">
<original>L</original>
<variation>LL</variation>
<location>
<position position="6"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_046265" evidence="60">
<original>VVVLNSKRTIEEAMVKKWADFAGRPEPLTYKLVSK</original>
<variation>KLVSR</variation>
<location>
<begin position="68"/>
<end position="102"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP21A2*2." id="VAR_018363" evidence="24 43 46 49">
<original>L</original>
<variation>LL</variation>
<location>
<position position="9"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; non-classic form; unknown pathological significance; no effect on steroid 21-monooxygenase activity." id="VAR_077582" evidence="45">
<original>L</original>
<variation>M</variation>
<location>
<position position="12"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; salt wasting form; unknown pathological significance; no significant difference in steroid 21-monooxygenase activity; dbSNP:rs63749090." id="VAR_026059" evidence="21 29">
<original>A</original>
<variation>T</variation>
<location>
<position position="15"/>
</location>
</feature>
<feature type="sequence variant" description="Decreased steroid 21-monooxygenase activity; dbSNP:rs757608533." id="VAR_077583" evidence="45">
<original>R</original>
<variation>C</variation>
<location>
<position position="16"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; non-classic form; 10% of non-classic AH3 Texan patients; 50% steroid 21-monooxygenase activity; dbSNP:rs9378251." id="VAR_001281" evidence="6 8 9 11 12 13 14 15 19 20 21 28 29 31 32 34 40">
<original>P</original>
<variation>L</variation>
<location>
<position position="30"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; does not affect membrane binding; enzyme function abolished." id="VAR_026060" evidence="5">
<original>P</original>
<variation>Q</variation>
<location>
<position position="30"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; loss of activity." id="VAR_065668" evidence="35">
<original>G</original>
<variation>R</variation>
<location>
<position position="56"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; non-classic form; simple virilizing form when associated with a second mild mutation such as S-453 or L-30; activity is significantly reduced in association with S-453; dbSNP:rs9378252." id="VAR_018364" evidence="20 34 35">
<original>H</original>
<variation>L</variation>
<location>
<position position="62"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; no activity." id="VAR_007923" evidence="8">
<original>G</original>
<variation>E</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; simple virilizing form." id="VAR_065669" evidence="39">
<original>I</original>
<variation>T</variation>
<location>
<position position="77"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3." id="VAR_026061" evidence="6">
<original>G</original>
<variation>V</variation>
<location>
<position position="90"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_001282">
<original>K</original>
<variation>R</variation>
<location>
<position position="98"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP21A2*3; dbSNP:rs6474." id="VAR_001283" evidence="24 28 46">
<original>K</original>
<variation>R</variation>
<location>
<position position="102"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; dbSNP:rs550051210." id="VAR_001284" evidence="27 55">
<original>P</original>
<variation>L</variation>
<location>
<position position="105"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; loss of activity; dbSNP:rs957886272." id="VAR_065670" evidence="35">
<original>L</original>
<variation>R</variation>
<location>
<position position="107"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; non-classic form; loss of steroid 21-monooxygenase activity." id="VAR_077584" evidence="45">
<original>S</original>
<variation>F</variation>
<location>
<position position="113"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; non-classic form; reduced activity; decreased affinity for 17-hydroxyprogesterone and progesterone; dbSNP:rs547552654." id="VAR_065671" evidence="36">
<original>K</original>
<variation>Q</variation>
<location>
<position position="121"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; dbSNP:rs72552750." id="VAR_026062" evidence="25">
<original>R</original>
<variation>H</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; loss of activity." id="VAR_065672" evidence="35">
<original>L</original>
<variation>P</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; salt wasting form; loss of activity." id="VAR_065673" evidence="39">
<original>L</original>
<variation>P</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; loss of hydroxylase activity toward 17-hydroxyprogesterone and progesterone." id="VAR_075372" evidence="33">
<original>C</original>
<variation>R</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3." id="VAR_001285" evidence="4">
<original>C</original>
<variation>Y</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; simple virilizing form; 1-4% activity; dbSNP:rs6475." id="VAR_001286" evidence="3 6 8 9 11 12 13 14 15 19 20 21 22 26 28 31 32 34 35 38 39 43 47 51 52 54">
<original>I</original>
<variation>N</variation>
<location>
<position position="172"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; dbSNP:rs72552751." id="VAR_026063" evidence="6">
<original>G</original>
<variation>A</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; loss of enzymatic activity toward 17-hydroxyprogesterone and progesterone; dbSNP:rs772317717." id="VAR_075373" evidence="33">
<original>G</original>
<variation>R</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP21A2*4; dbSNP:rs397515531." id="VAR_001287">
<original>D</original>
<variation>E</variation>
<location>
<position position="183"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; exhibits low enzymatic activity toward 17-hydroxyprogesterone and progesterone." id="VAR_075374" evidence="42">
<original>Y</original>
<variation>H</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; moderate." id="VAR_008688" evidence="58">
<location>
<position position="196"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; dbSNP:rs143240527." id="VAR_075375" evidence="41">
<original>L</original>
<variation>F</variation>
<location>
<position position="198"/>
</location>
</feature>
<feature type="sequence variant" description="Decreased steroid 21-monooxygenase activity; dbSNP:rs372964292." id="VAR_077585" evidence="45">
<original>S</original>
<variation>G</variation>
<location>
<position position="202"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; non-classic form; pathogenicity uncertain." id="VAR_026064" evidence="48">
<original>V</original>
<variation>L</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3." id="VAR_065674" evidence="39">
<original>I</original>
<variation>T</variation>
<location>
<position position="230"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3." id="VAR_065675" evidence="39">
<original>R</original>
<variation>K</variation>
<location>
<position position="233"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; salt wasting form; dbSNP:rs111647200." id="VAR_001288" evidence="8 9 28 32 52">
<original>I</original>
<variation>N</variation>
<location>
<position position="236"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; salt wasting form; dbSNP:rs12530380." id="VAR_001289" evidence="9 28 32">
<original>V</original>
<variation>E</variation>
<location>
<position position="237"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; salt wasting form; dbSNP:rs6476." id="VAR_001290" evidence="9 28 32">
<original>M</original>
<variation>K</variation>
<location>
<position position="239"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; dbSNP:rs750337015." id="VAR_026065" evidence="14">
<original>L</original>
<variation>P</variation>
<location>
<position position="261"/>
</location>
</feature>
<feature type="sequence variant" description="Decreased steroid 21-monooxygenase activity; dbSNP:rs61732108 and dbSNP:rs142028935." id="VAR_077586" evidence="45">
<original>P</original>
<variation>L</variation>
<location>
<position position="267"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP21A2*5; dbSNP:rs6472." id="VAR_001291" evidence="7 11 40 46">
<original>S</original>
<variation>T</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; salt wasting form." id="VAR_026066" evidence="12">
<original>V</original>
<variation>G</variation>
<location>
<position position="281"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; non-classic form; 50% activity; most common variant; normal KM but 20% reduced Vmax; dbSNP:rs6471." id="VAR_001292" evidence="4 6 7 8 9 10 11 12 13 15 19 20 21 22 28 29 32 37 39 48 49 50 52">
<original>V</original>
<variation>L</variation>
<location>
<position position="281"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; exhibits low enzymatic activity toward 17-hydroxyprogesterone and progesterone." id="VAR_075376" evidence="42">
<original>H</original>
<variation>N</variation>
<location>
<position position="282"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3." id="VAR_026067" evidence="19">
<original>M</original>
<variation>L</variation>
<location>
<position position="283"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3." id="VAR_026068" evidence="6">
<original>G</original>
<variation>C</variation>
<location>
<position position="291"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; dbSNP:rs201552310." id="VAR_018365" evidence="22">
<original>G</original>
<variation>R</variation>
<location>
<position position="291"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; salt wasting form; less then 1% activity; dbSNP:rs201552310." id="VAR_001293" evidence="8 15 27 28 39 58">
<original>G</original>
<variation>S</variation>
<location>
<position position="291"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; salt wasting form; less then 1% activity." id="VAR_065676" evidence="39">
<original>G</original>
<variation>D</variation>
<location>
<position position="292"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; salt wasting form; dbSNP:rs765001985." id="VAR_026069" evidence="12">
<original>L</original>
<variation>F</variation>
<location>
<position position="300"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3." id="VAR_018366" evidence="22">
<original>S</original>
<variation>Y</variation>
<location>
<position position="301"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; loss of enzymatic activity toward 17-hydroxyprogesterone and progesterone." id="VAR_075377" evidence="33">
<original>W</original>
<variation>R</variation>
<location>
<position position="302"/>
</location>
</feature>
<feature type="sequence variant" description="In hyperandrogenism; due to 21-hydroxylase deficiency; non-classic type; residual activity of 46% for conversion of 17-hydroxyprogesterone and 26% for conversion of progesterone compared with the normal enzyme; dbSNP:rs151344505." id="VAR_026070" evidence="17">
<original>V</original>
<variation>M</variation>
<location>
<position position="304"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3." id="VAR_026071" evidence="13">
<original>L</original>
<variation>M</variation>
<location>
<position position="317"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; simple virilizing form; 4% activity." id="VAR_065677" evidence="39">
<original>E</original>
<variation>K</variation>
<location>
<position position="320"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; non-classic form; 50% activity; dbSNP:rs72552754." id="VAR_001294" evidence="24">
<original>R</original>
<variation>H</variation>
<location>
<position position="339"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; simple virilizing form." id="VAR_018367" evidence="20 22 39">
<original>R</original>
<variation>P</variation>
<location>
<position position="341"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; non-classic form; mild; dbSNP:rs72552755." id="VAR_001295">
<original>R</original>
<variation>W</variation>
<location>
<position position="341"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; salt wasting form; dbSNP:rs772900496." id="VAR_026072" evidence="12">
<original>R</original>
<variation>C</variation>
<location>
<position position="354"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; salt wasting form; dbSNP:rs760216630." id="VAR_026073" evidence="6 39">
<original>R</original>
<variation>H</variation>
<location>
<position position="354"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; salt wasting form; 0.15% activity." id="VAR_001296" evidence="57">
<original>R</original>
<variation>P</variation>
<location>
<position position="356"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; simple virilizing form; mild; 0.65% activity; dbSNP:rs574370139." id="VAR_001297" evidence="4 28 57">
<original>R</original>
<variation>Q</variation>
<location>
<position position="356"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; salt wasting form; dbSNP:rs7769409." id="VAR_001298" evidence="3 6 8 9 10 11 12 13 14 15 19 20 22 26 28 31 32 34 35 39 43">
<original>R</original>
<variation>W</variation>
<location>
<position position="356"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; no activity." id="VAR_007924" evidence="8">
<original>A</original>
<variation>V</variation>
<location>
<position position="362"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3." id="VAR_026074" evidence="16">
<original>L</original>
<variation>W</variation>
<location>
<position position="363"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3." id="VAR_026075" evidence="28">
<original>H</original>
<variation>Y</variation>
<location>
<position position="365"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; dbSNP:rs781074931." id="VAR_065678" evidence="39">
<original>R</original>
<variation>W</variation>
<location>
<position position="369"/>
</location>
</feature>
<feature type="sequence variant" description="In hyperandrogenism; due to 21-hydroxylase deficiency; almost completely abolished enzyme activity; dbSNP:rs151344506." id="VAR_026076" evidence="17">
<original>G</original>
<variation>S</variation>
<location>
<position position="375"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; salt wasting form; dbSNP:rs72552756." id="VAR_001299" evidence="56">
<original>E</original>
<variation>D</variation>
<location>
<position position="380"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; salt wasting form; loss of steroid 21-monooxygenase activity." id="VAR_077587" evidence="45">
<location>
<begin position="389"/>
<end position="391"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; very low residual activity; dbSNP:rs72552757." id="VAR_026077" evidence="18 35 39">
<original>R</original>
<variation>C</variation>
<location>
<position position="408"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; very low activity; dbSNP:rs72552758." id="VAR_026078" evidence="10 15 18 39">
<original>G</original>
<variation>S</variation>
<location>
<position position="424"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; loss of enzymatic activity toward 17-hydroxyprogesterone and progesterone." id="VAR_075378" evidence="33">
<original>R</original>
<variation>C</variation>
<location>
<position position="426"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; loss of enzymatic activity toward 17-hydroxyprogesterone; dbSNP:rs151344504." id="VAR_026079" evidence="15 33 39">
<original>R</original>
<variation>H</variation>
<location>
<position position="426"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; dbSNP:rs767333157." id="VAR_026080" evidence="13">
<original>R</original>
<variation>C</variation>
<location>
<position position="435"/>
</location>
</feature>
<feature type="sequence variant" description="Decreased steroid 21-monooxygenase activity." id="VAR_077588" evidence="45">
<original>T</original>
<variation>M</variation>
<location>
<position position="450"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; salt wasting form; loss of steroid 21-monooxygenase activity." id="VAR_077589" evidence="45">
<original>T</original>
<variation>P</variation>
<location>
<position position="450"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; non-classic form; simple virilizing form when associated with L-62; 50% of activity; almost completely abolished enzyme activity when associated with S-375; dbSNP:rs6445." id="VAR_001300" evidence="6 7 12 13 15 17 19 20 21 23 24 27 28 34 35 36 39 55">
<original>P</original>
<variation>S</variation>
<location>
<position position="453"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; dbSNP:rs184649564." id="VAR_026081" evidence="28">
<original>R</original>
<variation>L</variation>
<location>
<position position="479"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; reduced enzyme activity to 70% of normal; dbSNP:rs776989258." id="VAR_026082" evidence="29 45">
<original>P</original>
<variation>S</variation>
<location>
<position position="482"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; moderate; 1-2% of activity; dbSNP:rs200005406." id="VAR_001301" evidence="14 15 20 28 52 53 58">
<original>R</original>
<variation>P</variation>
<location>
<position position="483"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; dbSNP:rs200005406." id="VAR_018368" evidence="22">
<original>R</original>
<variation>Q</variation>
<location>
<position position="483"/>
</location>
</feature>
<feature type="sequence variant" description="In AH3; salt wasting form; dbSNP:rs759736443." id="VAR_026083" evidence="26">
<original>R</original>
<variation>W</variation>
<location>
<position position="483"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP21A2*6; dbSNP:rs6473." id="VAR_001302" evidence="7 11 24 30 46 52">
<original>N</original>
<variation>S</variation>
<location>
<position position="493"/>
</location>
</feature>
<feature type="mutagenesis site" description="No loss of function." evidence="37">
<original>S</original>
<variation>C</variation>
<variation>M</variation>
<variation>T</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="mutagenesis site" description="Normal KM but 50% reduced Vmax.">
<original>V</original>
<variation>I</variation>
<location>
<position position="281"/>
</location>
</feature>
<feature type="mutagenesis site" description="Normal KM but 10% reduced Vmax.">
<original>V</original>
<variation>T</variation>
<location>
<position position="281"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activity and loss of P450 absorption." evidence="37">
<original>C</original>
<variation>M</variation>
<variation>S</variation>
<variation>T</variation>
<location>
<position position="428"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; BAB70774." ref="7" evidence="61">
<original>G</original>
<variation>D</variation>
<location>
<position position="155"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; BAB70774." ref="7" evidence="61">
<original>R</original>
<variation>G</variation>
<location>
<position position="242"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; BAB70774." ref="7" evidence="61">
<original>L</original>
<variation>Q</variation>
<location>
<position position="277"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; BAB70774." ref="7" evidence="61">
<original>V</original>
<variation>A</variation>
<location>
<position position="304"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 14; AAA59985." ref="14" evidence="61">
<original>P</original>
<variation>L</variation>
<location>
<position position="311"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 14; AAA59985." ref="14" evidence="61">
<original>N</original>
<variation>I</variation>
<location>
<position position="346"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAB59440." ref="1" evidence="61">
<original>R</original>
<variation>P</variation>
<location>
<position position="426"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAB59440." ref="1" evidence="61">
<original>E</original>
<variation>D</variation>
<location>
<position position="437"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="38"/>
<end position="40"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="44"/>
<end position="50"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="52"/>
<end position="55"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="57"/>
<end position="63"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="66"/>
<end position="71"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="74"/>
<end position="81"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="82"/>
<end position="84"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="85"/>
<end position="88"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="95"/>
<end position="99"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="114"/>
<end position="128"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="129"/>
<end position="134"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="135"/>
<end position="150"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="160"/>
<end position="177"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="179"/>
<end position="182"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="183"/>
<end position="185"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="187"/>
<end position="201"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="204"/>
<end position="211"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="213"/>
<end position="216"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="223"/>
<end position="245"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="256"/>
<end position="261"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="278"/>
<end position="309"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="311"/>
<end position="324"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="336"/>
<end position="338"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="343"/>
<end position="355"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="369"/>
<end position="373"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="376"/>
<end position="378"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="383"/>
<end position="386"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="388"/>
<end position="392"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="395"/>
<end position="397"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="398"/>
<end position="400"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="406"/>
<end position="409"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="431"/>
<end position="446"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="449"/>
<end position="457"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="478"/>
<end position="482"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4Y8W"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250"/>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10051010"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10094562"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10198222"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10364682"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10391209"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10408778"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10408786"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10443693"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10496074"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10720040"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11232002"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11598371"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11600539"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11746135"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12050257"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12213891"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12222711"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12788866"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12887291"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12915679"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1406699"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1406709"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14676460"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14715874"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1496017"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15110320"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15126570"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16046588"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1644925"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16984992"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18319307"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18381579"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18445671"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1864962"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1937474"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20080860"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2072928"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21169732"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22014889"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2303461"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25855791"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27721825"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3038528"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3257825"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3260007"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3267225"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3497399"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3871526"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7749410"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8478006"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8485582"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8989258"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9067760"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9187661"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9497336"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9580109"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000305"/>
<sequence length="494" mass="55887" checksum="7E1FF83B59FBA136" modified="1988-01-01" version="1">
MLLLGLLLLPLLAGARLLWNWWKLRSLHLPPLAPGFLHLLQPDLPIYLLGLTQKFGPIYR
LHLGLQDVVVLNSKRTIEEAMVKKWADFAGRPEPLTYKLVSKNYPDLSLGDYSLLWKAHK
KLTRSALLLGIRDSMEPVVEQLTQEFCERMRAQPGTPVAIEEEFSLLTCSIICYLTFGDK
IKDDNLMPAYYKCIQEVLKTWSHWSIQIVDVIPFLRFFPNPGLRRLKQAIEKRDHIVEMQ
LRQHKESLVAGQWRDMMDYMLQGVAQPSMEEGSGQLLEGHVHMAAVDLLIGGTETTANTL
SWAVVFLLHHPEIQQRLQEELDHELGPGASSSRVPYKDRARLPLLNATIAEVLRLRPVVP
LALPHRTTRPSSISGYDIPEGTVIIPNLQGAHLDETVWERPHEFWPDRFLEPGKNSRALA
FGCGARVCLGEPLARLELFVVLTRLLQAFTLLPSGDALPSLQPLPHCSVILKMQPFQVRL
QPRGMGAHSPGQNQ
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>